AIM
DARE icon

Acrospire Investment Management’s Dare Bioscience DARE Stock Holding History

Acrospire Investment Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-28
Closed -$4K – 2250
2016
Q3 		$4K Buy
+28
New +$6.27K ﹤0.01% 1850

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Acrospire Investment Management's DARE Position: Q4 2016 in Review

Acrospire Investment Management sold out of Dare Bioscience (DARE) in Q4 2016, closing a stake of 28 shares — an estimated $4K sold.

Acrospire Investment Management first reported a position in DARE in Q3 2016 and held it in 1 quarter. The position peaked at $4K in Q3 2016. 30 funds tracked by Wall St. Rank hold DARE as of Q4 2016.

  • Acrospire Investment Management reported no remaining Dare Bioscience position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 28 Dare Bioscience shares in Q4 2016, an estimated $4K.
  • Acrospire Investment Management first reported a position in Dare Bioscience in Q3 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Dare Bioscience position peaked at $4K in Q3 2016.
  • 30 funds tracked by Wall St. Rank held Dare Bioscience as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.